Clinical Trial Update: Docetaxel, Carboplatin, and Pegfilgrastim in Treating Patients Who Are Undergoing Surgery for Stage II or Stage III Breast Cancer [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating docetaxel, carboplatin, and pegfilgrastim in patients undergoing surgery for stage II/III breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• CARBOPLATIN (Carboplatin)
• DOCETAXEL (DOCETAXEL)
• Pegfilgrastim (pegfilgrastim)

Snippet

Sponsor: Alliance for Clinical Trials in Oncology | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED